Whole-exome sequencing of fibroblast and its iPS cell lines derived from a patient diagnosed with xeroderma pigmentosum
- PMID: 26697316
- PMCID: PMC4664661
- DOI: 10.1016/j.gdata.2015.07.008
Whole-exome sequencing of fibroblast and its iPS cell lines derived from a patient diagnosed with xeroderma pigmentosum
Abstract
Cells from a patient with a DNA repair-deficiency disorder are anticipated to bear a large number of somatic mutations. Because such mutations occur independently in each cell, there is a high degree of mosaicism in patients' tissues. While major mutations that have been expanded in many cognate cells are readily detected by sequencing, minor ones are overlaid with a large depth of non-mutated alleles and are not detected. However, cell cloning enables us to observe such cryptic mutations as well as major mutations. In the present study, we focused on a fibroblastic cell line that is derived from a patient diagnosed with xeroderma pigmentosum (XP), which is an autosomal recessive disorder caused by a deficiency in nucleotide excision repair. By making a list of somatic mutations, we can expect to see a characteristic pattern of mutations caused by the hereditary disorder. We cloned a cell by generating an iPS cell line and performed a whole-exome sequencing analysis of the progenitor and its iPS cell lines. Unexpectedly, we failed to find causal mutations in the XP-related genes, but we identified many other mutations including homozygous deletion of GSTM1 and GSTT1. In addition, we found that the long arm of chromosome 9 formed uniparental disomy in the iPS cell line, which was also confirmed by a structural mutation analysis using a SNP array. Type and number of somatic mutations were different from those observed in XP patients. Taken together, we conclude that the patient might be affected by a different type of the disorder and that some of the mutations that we identified here may be responsible for exhibiting the phenotype. Sequencing and SNP-array data have been submitted to SRA and GEO under accession numbers SRP059858 and GSE55520, respectively.
Keywords: Melanoma; Patient iPS cell; Sun burn; Suntan; Xeroderma pigmentosum.
Figures

Similar articles
-
Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.Gene. 2014 Jan 1;533(1):52-6. doi: 10.1016/j.gene.2013.09.125. Epub 2013 Oct 14. Gene. 2014. PMID: 24135642
-
Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US Population.JAMA Dermatol. 2019 Jan 1;155(1):72-78. doi: 10.1001/jamadermatol.2018.4473. JAMA Dermatol. 2019. PMID: 30516811 Free PMC article.
-
Whole-Exome Sequencing Enables the Diagnosis of Variant-Type Xeroderma Pigmentosum.Front Genet. 2019 May 24;10:495. doi: 10.3389/fgene.2019.00495. eCollection 2019. Front Genet. 2019. PMID: 31178899 Free PMC article.
-
Molecular genetics of Xeroderma pigmentosum variant.Exp Dermatol. 2003 Oct;12(5):529-36. doi: 10.1034/j.1600-0625.2003.00124.x. Exp Dermatol. 2003. PMID: 14705792 Review.
-
Sunlight, Vitamin D, and Xeroderma Pigmentosum.Adv Exp Med Biol. 2020;1268:319-331. doi: 10.1007/978-3-030-46227-7_16. Adv Exp Med Biol. 2020. PMID: 32918226 Review.
Cited by
-
Xeroderma Pigmentosum: A Genetic Condition Skin Cancer Correlated-A Systematic Review.Biomed Res Int. 2022 Jul 18;2022:8549532. doi: 10.1155/2022/8549532. eCollection 2022. Biomed Res Int. 2022. PMID: 35898688 Free PMC article.
-
Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers.Front Oncol. 2023 Oct 25;13:1282823. doi: 10.3389/fonc.2023.1282823. eCollection 2023. Front Oncol. 2023. PMID: 37954081 Free PMC article.
-
Frequent retrotransposition of endogenous genes in ERCC2-deficient cells derived from a patient with xeroderma pigmentosum.Stem Cell Res Ther. 2019 Aug 27;10(1):273. doi: 10.1186/s13287-019-1381-z. Stem Cell Res Ther. 2019. PMID: 31455402 Free PMC article.
-
Autonomous trisomic rescue of Down syndrome cells.Lab Invest. 2019 Jun;99(6):885-897. doi: 10.1038/s41374-019-0230-0. Epub 2019 Feb 13. Lab Invest. 2019. PMID: 30760866 Free PMC article.
-
Relationship between XPA, XPB/ERCC3, XPF/ERCC4, and XPG/ERCC5 Polymorphisms and the Susceptibility to Head and Neck Carcinoma: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.Medicina (Kaunas). 2024 Mar 14;60(3):478. doi: 10.3390/medicina60030478. Medicina (Kaunas). 2024. PMID: 38541204 Free PMC article.
References
-
- Li L., Bales E.S., Peterson C.A., Legerski R.J. Characterization of molecular defects in xeroderma pigmentosum group C. Nat. Genet. 1993;5(4):413–417. - PubMed
-
- Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature. 2009;460(7251):49–52. - PubMed
-
- Gore A., Li Z., Fung H.L., Young J.E., Agarwal S., Antosiewicz-Bourget J., Canto I., Giorgetti A., Israel M.A., Kiskinis E., Lee J.H., Loh Y.H., Manos P.D., Montserrat N., Panopoulos A.D., Ruiz S., Wilbert M.L., Yu J., Kirkness E.F., Izpisua Belmonte J.C., Rossi D.J., Thomson J.A., Eggan K., Daley G.Q., Goldstein L.S., Zhang K. Somatic coding mutations in human induced pluripotent stem cells. Nature. 2011;471(7336):63–67. - PMC - PubMed
-
- Young M.A., Larson D.E., Sun C.W., George D.R., Ding L., Miller C.A., Lin L., Pawlik K.M., Chen K., Fan X., Schmidt H., Kalicki-Veizer J., Cook L.L., Swift G.W., Demeter R.T., Wendl M.C., Sands M.S., Mardis E.R., Wilson R.K., Townes T.M., Ley T.J. Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell. 2012;10(5):570–582. - PMC - PubMed
-
- Sato K., Ikenaga M., Sano S. Kinetic analysis of polyethylene glycol-induced cell fusion in cultured human fibroblasts: its application to genetic complementation analysis of xeroderma pigmentosum. Med. J. Osaka Univ. 1982;33(1–2):19–28. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous